Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 425-400-6 | CAS number: 179986-09-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Short description of key information on bioaccumulation potential result:
Experimental data is not available. Based on the chemical structures of the components and on the subacute and subchronic toxicity data, no hazard for bioaccumulation is identified.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
The substance contains several components. All of them either have a log Pow of less than 3 or they have a log Pow of >> 3 and contain an ester function that may undergo enzymatic hydrolysis. The toxicity profile is consistent with an adaptive and reversible liver enlargement. Therefore, the substance is considered to be non bioaccumulating.
Discussion on bioaccumulation potential result:
The substance is a mixture of esters generated from reacting glycerol, a natural oil and a sterically hindered phenol-alkylene-carboxylic acid. Considering the reversible liver enlargement observed upon subacute oral exposure, systemic uptake and elimination of at least some components are assumed. Systemic availability of the individual components will be different depending on their molecular weight, the log Pow and the bulkiness of the molecule. For the most bulky structure, which is a trimester of glycerol and thesterically hindered phenol-alkylene-carboxylic acid,modelling of the size gave for the smallest and largest diameter a length of 13 and 16 Angstöm, respectively. It has a calculated log Pow of 15.2 and a molecular mass of 873 g/mol. In contrast, the UVCB substance also contains glycerol and the monoester of glycerol and thesterically hindered phenol-alkylene-carboxylic acidwhich should be are easily taken up.
In the determination of water solubility, only two components were detected. It is expected that one component is unreacted glycerol and the other is the monoester of glycerol and the thesterically hindered phenol-alkylene-carboxylic acid. All other components are of higher molecular weight and contain a more lipophilic functions (eg alkyl-chains.). In the initiatial experimental determination of the log Pow, all of the UVCB substance was found in the octanol phase and nothing was detected in the aqueous phase.
The log POWwas therefore calculated for the different components showing that components adding up to 50% of the substance have a log Pow of > 9.
Esters of the sterically hindered phenol-alkylene-carboxylic acidand glycerol are expected to undergo enzymatic ester hydrolysis. Toxicokinetic data on the methyl ester of the sterically hindered phenol-alkylene-carboxylic acid is available in the registrant's files showing efficient hydrolysis and elimination of the acid (or its metabolites) via kidney and bile. The bulky groups are not too close to the ester bond for steric hindrance of hydrolytic enzymes.
The sterically hindered phenol-alkylene-carboxylic acid may in theory undergo oxidative metabolism at the side chain substituent. This substance is related to the food additive BHT (butylated hydroxytoluene) for which such metabolic transformations have been described. Phase-II conjugation at the hydroxy-group may be hindered by the bulky groups. Both pathways involve xenobiotic metabolism enzymes that are highly inducible in rat liver. This is consistent with the reversible liver enlargement observed in the rat studies.
For the fraction containing esters of the oil and glycerol, normal metabolism in analgoy to dietary fat is expected. Glycerol and natural oel acids are not expected to contribute to the hazard profile (enzyme induction in liver and secondary thyroid effects.)
Systemic availability upon ingestion is expected to be most efficient because the UVCB substance is a viscous liquid that becomes emulgated by the bile. It is structurally related to fat and as such uptake and metabolism is facilitated.
In contrast, no such facilitation occurs for the dermal route of exposure. The UVCB substance is not surface active and therefore does not facilitate its own uptake. The molecular weights of the components that are a glyercol ester with at least twosterically hindered phenol-alkylene-carboxylic acids or one sterically hindered phenol-alkylene-carboxylic acid and one natural oil acid are all higher than 500 g/mol. For these components, the calculated log POWvalues are higher than 9. In accordance with ECHA guidance documents, skin permeability of these components is unlikely and a default uptake of 10% is given. The component that may be sufficiently small and soluble for uptake is present in the mixture at less than 20%. So overall, a permeability of 30% is assumed.
In addition, the sterically hindered phenol-alkylene-carboxylic acid is the moiety that causes the effects on liver. The poorly permeating components contain one, two ore three times the number of this moiety and therefore, the permeating component is the one contributing least to the liver effects. For DNEL-derivation, an additional factor of 0.5 is used to take this into account.
Regarding the inhalation route, exposure is expected to be very low as the substance is a viscous liquid and the components contributing to the effects on liver have a very low vapour pressure. Esterases are ubiquous enzymes, so in principle, no difference in hazard profile is expected for any route of exposure.
Overall, the substance is not considered to be bioaccumulating.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.